Rainbow Children's Medicare Limited

BSE: 543524 | NSE: RAINBOW

Sector: Healthcare | Industry: Hospital

REVENUE

₹ 1,703 Crore

Topline YoY ▲ 12.4%

GROSS PROFIT

₹ 1,476 Crore

Cost efficiency ▲ 11.7%

EBITDA

₹ 544 Crore

Operating leverage ▲ 11.1%

NET PROFIT

₹ 282 Crore

Net profitability ▲ 15.3%

ABOUT COMPANY

Rainbow Children’s Medicare Limited (hereafter referred to as ‘Rainbow’) was originally incorporated in 1998 with the name Rainbow Children’s Medicare Private Limited but the company converted into public company in 2021 and the name changed to Rainbow Children’s Medicare Limited. The company was founded by Dr. Ramesh Kancharla with a 50 bed pediatric hospital in Banjara Hills, Hyderabad, Telangana.

Rainbow is a child and women care chain of hospitals offers Neonatology, Pediatric Intensive Care, Neonatal Intensive Care, Neurology, Gastroenterology, Nephrology, Hematology and Oncology, Pediatric Surgery, Cardiology, Nutrition and Gynecology.

The company generates revenue in 3 ways viz. hospitals, pharmacy and clinics.

Metric	Value	Metric	Value
Hospitals	24	Capacity beds	2435
Out-patient clinics	5	Out-patient visits	1,598k+
States, Cities	6,9	In-patient admissions	104k+
Doctors	1,050+	Deliveries	19k+
City	Hospitals	Clinics
Hyderabad	8	2
Bengaluru	4	1
Vijayawada	2	1
Visakhapatnam	1	1

Pediatrics - Secondary Care	Pediatrics - Quaternary Care
Pediatrics - Tertiary Care	Perinatal/Women's Care

Location	Number of Hospitals	Number of Clinics	Total
National	23	5	29
International	-	-	-

Location	Number
National (No. of States)	6
International (No. of Countries)	0

State	City	Hospital Name	Bed Capacity	No. of Clinics
Telangana	Hyderabad	Banjara Hills (Rd. No. 2)	250	0
	Hyderabad	Banjara Hills (Rd. No. 10 - RCHI)	110	0
	Hyderabad	Hydernagar	160	0
	Hyderabad	LB Nagar	100	0
	Hyderabad	Financial District	100	0
	Hyderabad	Himayatnagar	60	0
	Hyderabad	Kondapur	50	1
	Hyderabad	Secunderabad (Vikrampuri)	110	0
	Hyderabad	Attapur & Madhapur	0	2
	Warangal	Hanamkonda (Prashanthi Hospital)	100	0
Karnataka	Bengaluru	Marathahalli	200	0
	Bengaluru	Bannerghatta Road	102	1
	Bengaluru	Electronic City	90	0
	Bengaluru	Sarjapur	90	0
	Bengaluru	Hebbal	50	0
	Bengaluru	HRBR Layout	60	0
	Bengaluru	Mahadevapura	0	1
	Bengaluru	Hennur	0	1
Andhra Pradesh	Vijayawada	Currency Nagar & Governorpet	130	1
	Visakhapatnam	Health City & Kailash Metta	129	1
	Rajahmundry	AV Appa Rao Road	100	0
Tamil Nadu	Chennai	Guindy	135	0
	Chennai	Anna Nagar	80	0
	Chennai	Sholinganallur	55	0
Assam	Guwahati	VIP Road, Borbari (Pratiksha Hospital)	150	0
Delhi NCR	New Delhi	Panchsheel Park (Rosewalk)	24	0
	New Delhi	Malviya Nagar (Madhukar Rainbow)	130	0
Total			2,565	8

Earning Calls Summary

Management Earnings Calls

Quarterly concall summaries, management commentary tracker & key metrics

Q4 FY 2026

FY26 Revenue Up 12%; 900+ Beds Pipeline with Zero Debt

Management opened noting FY26 as a landmark year with the highest annual capacity addition in history. The company successfully integrated acquired hospitals at Warangal and Guwahati, with new hospitals at Rajahmundry, HRBR, and Electronic City showing strong ramp-up.

FY26 EBITDA MARGIN 32.0% (₹544 crores, 11% YoY growth)

CASH POSITION (AS OF MAR 31, 2026) ~₹594-600 crores (zero debt)

IVF BUSINESS (FY26) ₹61.4 crores (3.7% of revenue; expected 25% YoY growth)

Key Takeaway: FY26 consolidated revenue grew 12% YoY to ₹1,703 crores with EBITDA of ₹544 crores (32% margin), while the company added 500 beds (highest annual capacity addition) and has 900+ beds in execution phase. Q4 revenue grew 24% YoY to ₹459.9 crores with PAT up 38% (17% ex-deferred tax).

Q2 FY 2027

Q2 Revenue Up 23% to ₹548 Cr; Margins Hold at 31% Despite Expansion

Management opened noting another quarter of robust growth with healthy numbers from mature, emerging, and new hospitals across inpatient volumes, outpatient footfalls, and deliveries — achieved in a seasonally soft quarter due to lack of monsoon. The company emphasized that it is moving away from dependence on seasonality, with performance driven by underlying pediatric and maternal care business.

Q2 FY27 REVENUE GROWTH 23.2% YoY to ₹548 crores

Q2 FY27 EBITDA MARGIN 31% (₹170 crores, 14.2% growth)

CASH POSITION (SEP 30, 2026) ₹542.8 crores (cash, FDs, and mutual fund investments)

Key Takeaway: Q2 FY27 revenue grew 23.2% YoY to ₹548 crores with EBITDA of ₹170 crores (31% margin, 14.2% growth) and PAT of ₹83.9 crores (10.9% growth). H1 revenue grew 27.6% YoY to ₹1,018 crores with EBITDA up 20.6% to ₹304.6 crores (29.9% margin). The company commenced operations at Nellore (70 beds) and Guntur (50 beds), and was allotted 2 acres in Amaravati for a 150-bed pediatric specialty hospital, with 1,050 beds in the pipeline.

PREMIUM

Unlock Comprehensive Analysis

Get deeper insights with detailed financials, forecasts, ratios & valuation

Revenue & Gross Margin

EBITDA & Dividend

Balance Sheet

DuPont & Ratio Analysis

Key Insights

Charts

Disclaimer

The research report presented here is for informational and research purposes only. It reflects our own views, assumptions, and analysis and is not intended as a recommendation, offer, or solicitation to buy, sell, or hold any security or asset. Please conduct your own due diligence and consult a qualified financial advisor before making any investment decision. Please check our Terms & Conditions page before investing.

Rainbow Children's Medicare Limited

BSE: 543524 | NSE: RAINBOW

Sector: Healthcare | Industry: Hospital

ABOUT COMPANY

Earning Calls Summary

Management Earnings Calls

Q3 Revenue Up 12%; New CEO Appointed to Drive Occupancy

FY26 Revenue Up 12%; 900+ Beds Pipeline with Zero Debt

Q1 Revenue Surges 33%; 2,500-Bed Pipeline Over 5 Years

Q2 Revenue Up 23% to ₹548 Cr; Margins Hold at 31% Despite Expansion

Quick Links

Legal Pages